News
Abbott announced it plans to initiate a randomized, controlled trial in the United States to evaluate the use of dual anti-platelet therapy (DAPT) for a three-month duration following treatment with the company's Xience family of drug eluting stents (DES).
October 31, 2013
News
Amaranth Medical, a privately held medical device company, presented positive six-month angiographic results from its first-in-human study including patients undergoing percutaneous coronary intervention (PCI) with single coronary lesions.
October 31, 2013
Feature | Dave Fornell
The CoreValve U.S. pivotal trial showed very positive results for the Medtronic CoreValve system, comparable or better than data from the Sapien Partner Trial.
October 30, 2013Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025
Technology
Terumo Interventional Systems announced the launch of the 0.018-inch Glidewire Advantage peripheral guidewire during the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco.
October 30, 2013
News
Philips and Infraredx Inc. announced a non-exclusive resale agreement for Infraredx’s TVC imaging system. Under the terms of the agreement, Philips will sell Infraredx’s TVC imaging system alongside its Allura interventional X-ray systems in North America and Europe.
October 30, 2013
News
The findings of a Harvey L. Neiman Health Policy Institute study published online in the Journal of the American College of Radiology (JACR) confirm a major shift in practice at American hospitals regarding central venous procedures.
October 29, 2013Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
OrbusNeich announced the publication of a study demonstrating that lesion preparation with the company’s Scoreflex coronary dilatation catheter prior to drug eluting stent (DES) implantation is associated with equivalent acute stent expansion and less in-stent late loss versus a non-compliant balloon.
October 29, 2013
Technology
Nonin Medical Inc., the inventor of finger pulse oximetry and a leader in noninvasive medical monitoring, announced that the U.S. Food and Drug Administration (FDA) has cleared the Nonin Model 3230 Bluetooth Smart finger pulse oximeter for use in the United States.
October 29, 2013
News
Biotronik Japan announced enrollment of the first patient in the Bioflow-IV study, which aims to verify the efficacy and safety of the Orsiro Hybrid Drug-Eluting Stent (DES) from Biotronik.
October 29, 2013Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
The American Society of Echocardiography (ASE) Foundation is announced the Echo AUC, a new mobile application that is designed to guide physicians in appropriate procedures in cardiovascular care and echocardiography, is available for download in both the Apple and Droid application stores.
October 28, 2013
News
Alivecor Inc. announced that the AliveCor Heart Monitor is now being offered to participants in the Health eHeart Study with 2,000 units to be deployed before the end of the year.
October 28, 2013
News
Researchers at The University of Texas Health Science Center at Houston (UTHealth) led a study that showed that a hands-free ultrasound device, combined with a clot-busting drug, was safe for ischemic stroke patients.
October 28, 2013Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
Biosensors International’s expanded product portfolio offers physicians a broader range of treatment options to improve patient outcomes.
October 28, 2013
News
Simbionix, a provider of innovative training solutions, announced the initiation of the REHEARSAAAL study which evaluates the clinical benefits of preoperative patient specific simulation using the PROcedure Rehearsal Studio for the treatment of Abdominal Aortic Aneurysms (AAAs) by Endovascular Aortic Repair (EVAR). A multidisciplinary group of physicians from vascular surgery, interventional radiology and cardiology departments in hospitals across the United States and Europe will conduct the study.
October 28, 2013News
CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education and advancement of medical technologies, will present data from the podium at the Transcatheter Cardiovascular Therapeutics annual scientific meeting (TCT 2013) that provides a seminal experimental and computational template for a more rational, comprehensive preclinical evaluation and optimization of renal denervation devices.
October 28, 2013